Natixis Advisors
UTMD icon

Natixis Advisors’s Utah Medical Products UTMD Stock Holding History

Natixis Advisors’s Portfolio UTMD Stock Details UTMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-12,811
Closed -$1.1M – 1571
2023
Q3 		$1.1M Buy
+12,811
New +$1.18M ﹤0.01% 1152
2020
Q4 		– Sell
-13,533
Closed -$1.08M – 1247
2020
Q3 		$1.08M Sell
13,533
-1,885
-12% -$156K 0.01% 935
2020
Q2 		$1.37M Buy
15,418
+3,727
+32% +$335K 0.01% 896
2020
Q1 		$1.1M Sell
11,691
-672
-5% -$62.4K 0.01% 882
2019
Q4 		$1.33M Sell
12,363
-196
-2% -$19.9K 0.01% 921
2019
Q3 		$1.2M Sell
12,559
-3,320
-21% -$309K 0.01% 892
2019
Q2 		$1.52M Sell
15,879
-605
-4% -$50.9K 0.01% 843
2019
Q1 		$1.46M Buy
16,484
+1,649
+11% +$145K 0.01% 844
2018
Q4 		$1.23M Sell
14,835
-2,245
-13% -$198K 0.01% 854
2018
Q3 		$1.61M Buy
+17,080
New +$1.63M 0.01% 830
2015
Q1 		– Sell
-11,412
Closed -$685K – 1053
2014
Q4 		$685K Sell
11,412
-516
-4% -$28.6K 0.01% 869
2014
Q3 		$582K Buy
11,928
+704
+6% +$35.8K 0.01% 884
2014
Q2 		$577K Buy
11,224
+3,294
+42% +$169K 0.01% 973
2014
Q1 		$459K Buy
+7,930
New +$433K 0.01% 965

Other funds holding UTMD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Natixis Advisors's UTMD Position: Q4 2023 in Review

Natixis Advisors sold out of Utah Medical Products (UTMD) in Q4 2023, closing a stake of 12,811 shares — an estimated $1.1M sold.

Natixis Advisors first reported a position in UTMD in Q1 2014 and held it in 14 quarters. The position peaked at $1.61M in Q3 2018. 89 funds tracked by Wall St. Rank hold UTMD as of Q4 2023.

  • Natixis Advisors reported no remaining Utah Medical Products position as of Q4 2023 after selling out during the quarter.
  • Natixis Advisors sold 12,811 Utah Medical Products shares in Q4 2023, an estimated $1.1M.
  • Natixis Advisors first reported a position in Utah Medical Products in Q1 2014 and held it in 14 quarters.
  • Natixis Advisors's Utah Medical Products position peaked at $1.61M in Q3 2018.
  • 89 funds tracked by Wall St. Rank held Utah Medical Products as of Q4 2023.

Based on Natixis Advisors's 13F filing for Q4 2023, filed 6 Feb 2024.